CTSC and cancer: Antioxidants, such as N-acetylcysteine (NAC) and diphenyleneiodonium (DPI), along with cathepsin C (CTSC) inhibitors like AZD7986, reduce ROS-driven NET formation, improving outcomes in models of sepsis and cancer metastasis.